31.3 C
Delhi
Monday, June 30, 2025

Dr Reddy Labs launches Lenalidomide Capsules in US

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Dr. Reddy’s Labs on Thursday announced the launch of Lenalidomide Capsules in the US market, , a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration (USFDA).

With this volume-limited launch, Dr. Reddy’s is eligible for first-to-market, 180 days of generic drug exclusivity for Lenalidomide Capsules in 2.5 mg and 20 mg strengths.

‘We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity,” says Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories.

“Bringing a more affordable generic version to market creates greater patient access for this important drug.’

Dr. Reddy’s Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg, and 25 mg strengths, each in a bottle-count size of 21.

Related articles

IITEX 2025 concludes in Hyd; Minister Sridhar Babu calls for expansion to tier-2 and tier-3 cities

Hyderabad: The second edition of the Industrial Innovation & Technology Expo (IITEX 2025), organised by the Federation of...

Kyrgyz president discusses bilateral, multilateral cooperation with Russian FM

Bishkek: Kyrgyz President Sadyr Japarov met with visiting Russian Foreign Minister Sergey Lavrov yesterday in the resort town...

Former Pentagon Aide claims US warned Iran about strikes 2 hours before attack

Washington: Former Pentagon adviser, retired US Army Col. Douglas Macgregor claims that Washington warned Iran about strikes on...

Iran strikes-damaged Haifa refinery likely to restart by October: Reports

Jerusalem: The Haifa refinery, which was damaged by Iran's strikes, is likely to fully resume operations by October,...